ATTENDS DAILY BARRIER- dimethicone, zinc oxide spray 
Purna Pharmaceuticals NV

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient                                        Purpose

Dimethicone 2% ............................... Skin Protectant

Zinc Oxide 4% .................................. Skin Protectant

Attends Professional Care

Prevents. Treats. Protects. 3in1

Attends Daily Barrier S[ray

Zinc Oxide & Dimethicone Skin Protectant

Gentle enough for daily use

Convenient and easy to use Pump Spray

(Spanish Panel)

(Spanish Section

Dermatologically Tested

Net Wt. 3.5 oz (99.2 g)

Keep out of reach of children. 

If swallowed, get medical help or contact a Poison Control Center immediately.

Uses

Warnings

For external use only

When using this product

Stop use and ask a doctor if

Directions

Other Information

Questions? Call 1-800-428-8363

Manufactured in Belgium

Distributed by: 

Attends Healthcare Products, Inc.

Greenville, NC 27834

www.Attends.com

Inactive Ingredients

aloe barbadensis gel, aqua, C12-15 alkyl benzoate, dimethicone, glyceryl stearate, L-Carnoside, methylparaben, microcrystalline cellulose, panthenol, paraffinum liquidum, parfum, PEG-100 stearate, propylene glycol, propylparaben, prunus amygdalus dulcis oil, sorbitan stearate, tocopherol, zinc oxide.

label image

ATTENDS DAILY BARRIER 
dimethicone, zinc oxide spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62450-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION4 g  in 99 g
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE2 g  in 99 g
Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
WATER (UNII: 059QF0KO0R)  
C12-15 ALKYL BENZOATE (UNII: A9EJ3J61HQ)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
CARNOSINE (UNII: 8HO6PVN24W)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
PANTHENOL (UNII: WV9CM0O67Z)  
MINERAL OIL (UNII: T5L8T28FGP)  
PEG-100 STEARATE (UNII: YD01N1999R)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
ALMOND OIL (UNII: 66YXD4DKO9)  
SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)  
TOCOPHEROL (UNII: R0ZB2556P8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62450-001-0199 g in 1 PACKAGE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34703/06/2014
Labeler - Purna Pharmaceuticals NV (372126946)
Establishment
NameAddressID/FEIBusiness Operations
Purna Pharmaceuticals NV372126946manufacture(62450-001)

Revised: 3/2014
Document Id: 9194048e-5b6d-4f5d-b410-79cca5382ff2
Set id: 03319707-8c1d-408c-b173-3c384ef1271c
Version: 1
Effective Time: 20140306
 
Purna Pharmaceuticals NV